Ironwood Pharmaceuticals (IRWD) Fair Value & DCF
Score
IRWD fair value $44.12. Price $4.83. Price is 89% below fair value.
Worked example
Cash-flow value. Starting free cash flow is $1.24 a share. Years 1 to 5 grow at 20.00%. Years 6 to 10 fade that rate in a straight line to 3% terminal growth. The discount rate is 8.70% (beta 0.80). It is beta-adjusted and capped at 12%. The cash-flow value is $55.71 a share.
Earnings value. Next-twelve-months earnings per share of $1.36 times 23.83 is $32.53. The peer group is Healthcare, 75 companies worth at least $10 billion. Peer median 30.7. Own 10-year median 17.0. The multiple used is the average of the two, kept between 8 and 30, which is 23.83.
Fair value is the average of the two, $44.12. The price is $4.83, which is 89.1% below fair value.